Skip to content
10-Q/A

Quarterly Report

REGENOCELL THERAPEUTICS, INC.

0001144204-11-050874

← back to feed
Filed
Sep 1, 2011 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2011 · Aug 15, 2011 81.96M sh
Capex Q2 2011 · Jun 30, 2011 $0
Capex Q2 2011 · Jun 30, 2010 $75K
Operating Cash Flow Q2 2011 · Jun 30, 2011 $477.31K
Operating Cash Flow Q2 2011 · Jun 30, 2010 $159.31K
Cash And Equivalents Q2 2011 · Jun 30, 2011 $58K
Cash And Equivalents Q2 2011 · Dec 31, 2010 $3.44K
Cash And Equivalents Q2 2011 · Jun 30, 2010 $54.06K
Cash And Equivalents Q2 2011 · Dec 31, 2009 $0
Stockholders Equity Q2 2011 · Jun 30, 2011 −$4.86M
Stockholders Equity Q2 2011 · Dec 31, 2010 −$4.36M
Stockholders Equity Q2 2011 · Dec 31, 2009 −$353.77K
Current Liabilities Q2 2011 · Jun 30, 2011 $2.05M
Current Liabilities Q2 2011 · Dec 31, 2010 $1.72M
Total Liabilities Q2 2011 · Jun 30, 2011 $5.22M
Total Liabilities Q2 2011 · Dec 31, 2010 $4.71M
Current Assets Q2 2011 · Jun 30, 2011 $215.77K
Current Assets Q2 2011 · Dec 31, 2010 $191.45K
Total Assets Q2 2011 · Jun 30, 2011 $361.54K
Total Assets Q2 2011 · Dec 31, 2010 $342.43K
Sga Expense Q2 2011 · Jun 30, 2011 $210.95K
Sga Expense Q2 2011 · Jun 30, 2011 $279.63K
Sga Expense Q2 2011 · Jun 30, 2010 $161.53K
Sga Expense Q2 2011 · Jun 30, 2010 $441.6K
Net Income Q2 2011 · Jun 30, 2011 −$360.04K
Net Income Q2 2011 · Jun 30, 2011 −$499.59K
Net Income Q2 2011 · Dec 31, 2010 −$4.06M
Net Income Q2 2011 · Jun 30, 2010 −$131.26K
Net Income Q2 2011 · Jun 30, 2010 −$498.72K
Operating Income Q2 2011 · Jun 30, 2011 −$276.25K
Operating Income Q2 2011 · Jun 30, 2011 −$325.14K
Operating Income Q2 2011 · Jun 30, 2010 $68.75K
Operating Income Q2 2011 · Jun 30, 2010 −$232.68K
Revenue Q2 2011 · Jun 30, 2011 $194.22K
Revenue Q2 2011 · Jun 30, 2011 $456.45K
Revenue Q2 2011 · Jun 30, 2010 $274.96K
Revenue Q2 2011 · Jun 30, 2010 $566.82K